Additionally, the distribution of patient survival status showed a clear trend: as TaNKFS increased, the proportion of deceased patients also increased (Fig. 5 E: METABRCA-TNBC, 5H: TCGA-TNBC, and 5K: GSE58812 ).
← all excerpts
Unleashing the potential role of tumor-associated NK cells as a novel immunotherapeutic target in triple-negative breast cancer.
1
—
—